Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $60.21 USD
Change Today +0.51 / 0.85%
Volume 701.3K
As of 4:15 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Donald E. Morel Jr., Ph.D.

Chairman and Chief Executive Officer, West Pharmaceutical Services, Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Donald E. Morel Jr., Ph.D. has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 2002. Dr. Morel served as the President of West Pharmaceutical Services Inc. from April 2002 to June 2005, Chief Operating Officer from May 2001 to April 2002, Division President, Drug Delivery Systems from October 1999 to May 2001, Group President from April 1998 to October 1999 and Vice President, Scientific Services since November 1992. Dr. Morel served ...

Read Full Background

Corporate Headquarters*

530 Herman O. West Drive
Exton, Pennsylvania 19341

United States

Phone: 610-594-2900
Fax: --

Board Members Memberships*

Former Director
Chairman and Chief Executive Officer
Former Director, Member of Audit Committee and Member of Compensation Committee
Director and Member of Compensation Committee


Lafayette College
Cornell University
Cornell University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$837,721

Stock Options*

Restricted Stock Awards$1,200,022
All Other Compensation$95,756
Exercisable Options844,568
Exercisable Options Value$27,753,243
Unexercisable Options462,638
Unexercisable Options Value$10,522,712
Total Value of Options$38,275,954
Total Number of Options1,307,206

Total Compensation*

Total Annual Cash Compensation$1,657,357
Total Short Term Compensation$837,721
Other Long Term Compensation$1,295,778
Total Calculated Compensation$4,889,983
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $60.21 USD +0.51


Jonathan W. Ayers Chairman, Chief Executive Officer and President
IDEXX Laboratories, Inc.
Walter M. Rosebrough Jr.Chief Executive Officer, President, Director and Member of Compliance Committee
Steris Corp.
Jeffrey T. Slovin Chief Executive Officer, President and Director
Sirona Dental Systems Inc.
Kevin J. McNamara Chief Executive Officer, President and Director
Chemed Corp.
Benson F. Smith Chairman, Chief Executive Officer, President and Member of Non-Executive Equity Awards Committee
Teleflex Incorporated
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at